CCL4 and atherosclerosis: To address this issue, the current study investigated whether the direct inhibition of CCL4 by a specific antibody could retard the progression of atherosclerosis and promote the stabilization of atheroma plaques in vivo and reduce TNF-α-induced endothelial adhesiveness to monocytic cells in vitro.